2.- EPATITE C

Vickerman P., Hickman M., May M., Kretzschmar M., Wiessing L., Can hepatitis C virus prevalence be used as a measure of injection-related human immunodeficiency virus risk in populations of injecting drug users? An ecological analysis., Addiction, 2010; 105 (2): 311 – 318

Schäfer A., Wittchen H., Backmund M., Soyka M., Gölz J., Siegert J., et al., Psychopathological changes and quality of life in hepatitis C virus-infected, opioid-dependent patients during maintenance therapy, Addiction, 2009; 104 (4): 630 - 640

Grebely J., Genoway K., Raffa J., Dhadwal G., Rajan T., Showler G., et al., Barriers associated with the treatment of hepatitis C virus infection among illicit drug users, Drug and Alcohol Dependence, 2008; 93 (1-2): 141 – 147 

Rhodes T., Zikic B., Prodanović A., Kuneski E., Bernays S., Hygiene and uncertainty in qualitative accounts of hepatitis C transmission among drug injectors in Serbia, Social Science & Medicine, 2008; 66 (6): 1437 – 1447

Bautista C., Pando M., Reynaga E., Marone R., Sateren W., Montano S., Sexual Practices, Drug Use Behaviors, and Prevalence of HIV, Syphilis, Hepatitis B and C, and HTLV-1/2 in Immigrant and Non-immigrant Female Sex Workers in Argentina, Journal of Immigrant and Minority Health, 2008

Rhodes T., Treloar C., The social production of hepatitis C risk among injecting drug users: a qualitative synthesis, Addiction, 2008; 103 (9): 1593 – 1603

Tedaldi E., Emerging therapies for hepatitis C and HIV in drug abusers: drugs and strategies, Journal of Addictive Diseases, 2008; 27 (2): 83 – 91

Foster G., Injecting drug users with chronic hepatitis C: should they be offered antiviral therapy?, Addiction, 2008; 103 (9): 1412 – 1413

Novick D., Kreek M. J., Critical issues in the treatment of hepatitis C virus infection in methadone maintenance patients, Addiction, 2008; 103 (6): 905 – 918

Bart G., Piccolo P., Zhang L., Jacobson I., Schaefer R., , Kreek M., Markers for hepatitis A, B and C in methadone maintained patients: an unexpectedly high co-infection with silent hepatitis B, Addiction, 2008; 103 (4): 681 – 686

Pontali E., Ferrari F., Prevalence of Hepatitis B virus and/or Hepatitis C virus co-infections in prisoners infected with the Human Immunodeficiency Virus, International Journal of Prisoner Health, 2008; 4 (2): 77 – 82

Brener L., Hippel W., Measuring attitudes toward injecting drug users and people with Hepatitis C., Substance Use & Misuse, 2008; 43 (3 - 4): 295 – 302

Grebely J., Genoway K., Raffa J., Dhadwal G., Rajan T., Showler G., et al., Barriers associated with the treatment of hepatitis C virus infection among illicit drug users, Drug and Alcohol Dependence, 2008; 93 (1-2): 141 – 147  

Novick D., Kreek M.,  Critical issues in the treatment of hepatitis C virus infection in methadone maintenance patients, Addiction; 2008; 103 (6): 905 - 918

Center for Disease Control and Prevention (CDC), Use of Enhanced Surveillance for Hepatitis C Virus Infection to Detect a Cluster Among Young Injection-Drug Users - New York, November 2004 - April 2007, MMWR. Morbidity and Mortality weekly report 2008; 57 (19): 517 - 521

Holtzman D., Viral hepatitis prevention - new challenges, new directions, American Journal of  Public Health, 2008; 98: 778

Maher L., Jalaludin B., Chant K., Jayasuriya R., Sladden T., Kaldor J. et al., Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia, Addiction, 2006; 101 (10): 1499-1508

Hopwood M., Treloar C., Bryant J., Hepatitis C and injectingrelated discrimination in New South Wales, Australia, Drugs Education Prevention & Policy, 2006; 13 (1): 61-75

Hutchinson S., Bird S., Taylor A., Goldberg D., Modelling the spread of hepatitis C virus infection among drug users in Glasgow: implications for prevention, The International Journal of Drug Policy, 2006; 17 (3): 211-221

Munoz Plaza C., Strauss S., Asione J., Des Jarlais Don C., Hogan H., Staff perspectives on facilitating the implementation of hepatitis C services at drug treatment programs, Journal of Psychoactive Drugs, 2006; 38 (3): 233-242

Guadagnino V., Trotta M.P., et al. Treatment of chronic Hepatitis C Virus infection in intravenous drug addicts: state-of-theart, Heroin Addiction and Related Clinical Problems, 2006; 8 (3): 37-48